<?xml version="1.0" encoding="UTF-8"?>
<p>Lately, MCT1 mRNA levels have been shown to be markedly reduced in the frontal cortex of CJD MM1 and VV2 patients [
 <xref rid="B16-ijms-22-01566" ref-type="bibr">16</xref>]. The cerebral cortex together with the cerebellum is one of the most frequently affected brain regions in CJD patients [
 <xref rid="B17-ijms-22-01566" ref-type="bibr">17</xref>,
 <xref rid="B18-ijms-22-01566" ref-type="bibr">18</xref>,
 <xref rid="B19-ijms-22-01566" ref-type="bibr">19</xref>].
</p>
